NOKOMIS, Fla.--(BUSINESS WIRE)--As Rainbow Biosciences (OTCBB: RBCC) seeks entry into the $3-billion-and-growing market for Parkinson’s disease treatments, population trends point to the likelihood that incidence of the disease will double in the next 20 years.
